SEI Investments’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-62,683
Closed -$915K – 3321
2026
Q2
$915K Buy
62,683
+31,539
+101% +$417K ﹤0.01% 2343
2026
Q1
$429K Sell
31,144
-75,388
-71% -$1.14M ﹤0.01% 2707
2025
Q4
$1.92M Buy
106,532
+25,650
+32% +$461K ﹤0.01% 1871
2025
Q3
$1.5M Sell
80,882
-74,056
-48% -$1.16M ﹤0.01% 1803
2025
Q2
$2.48M Sell
154,938
-174,055
-53% -$3.1M ﹤0.01% 1565
2025
Q1
$6.39M Sell
328,993
-79,050
-19% -$1.66M 0.01% 1163
2024
Q4
$8.99M Buy
408,043
+124,558
+44% +$2.4M 0.01% 1031
2024
Q3
$4.77M Buy
283,485
+141,841
+100% +$2.1M 0.01% 1304
2024
Q2
$1.69M Buy
141,644
+20,478
+17% +$229K ﹤0.01% 1709
2024
Q1
$1.34M Buy
121,166
+37,408
+45% +$382K ﹤0.01% 1773
2023
Q4
$725K Buy
83,758
+15,193
+22% +$118K ﹤0.01% 1974
2023
Q3
$525K Buy
68,565
+50,450
+278% +$379K ﹤0.01% 2095
2023
Q2
$130K Buy
+18,115
New +$106K ﹤0.01% 2529

Other funds holding CLBT

SEI Investments's CLBT Position: Q3 2026 in Review

SEI Investments sold out of Cellebrite (CLBT) in Q3 2026, closing a stake of 62,683 shares — an estimated $915K sold.

SEI Investments first reported a position in CLBT in Q2 2023 and held it in 13 quarters. The position peaked at $8.99M in Q4 2024. 83 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • SEI Investments reported no remaining Cellebrite position as of Q3 2026 after selling out during the quarter.
  • SEI Investments sold 62,683 Cellebrite shares in Q3 2026, an estimated $915K.
  • SEI Investments first reported a position in Cellebrite in Q2 2023 and held it in 13 quarters.
  • SEI Investments's Cellebrite position peaked at $8.99M in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.